Skip to content

A multicenter registration study of the effects of Traditional Chinese Medicine intervention on coronary artery obstruction

A multicenter registration study of the effects of Traditional Chinese Medicine intervention on coronary artery obstruction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200005545
Enrollment
Unknown
Registered
2022-01-17
Start date
2022-01-17
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Interventions

Observation group:Nil

Sponsors

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medicine Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with stable coronary artery disease. 1. Patients with severe coronary artery disease (CAD) who meet the diagnostic criteria for stable angina pectoris and the criteria for enrollment in coronary artery chronic obstruction and who meet the criteria for stent implantation or who undergo PCI treatment. 2. Patients who refuse stent implantation or PCI treatment and are willing to receive TCM evidence-based treatment for 3-6 months. 3. Commitment to submit the results of coronary angiography and other tests before and after treatment. 4. Signed informed consent by the TCM physician to join this study. 5. The patient signed the informed consent form to be visited before and after treatment.

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes mellitus, heart failure (NYHA cardiac function class III and above), and chronic viral or bacterial infections, malignancies, autoimmune diseases and other serious systemic diseases. 2. Those who are unable to obtain complete follow-up. 3. Those who are participating in another study. 4. Those who cannot receive long-term TCM discriminatory treatment.

Design outcomes

Primary

MeasureTime frame
Degree of improvement of coronary artery obstruction;

Secondary

MeasureTime frame
Symptom improvement rate;Rate of stenting or PCI treatment;Hematologic reconstruction rate;Incidence of acute cardiovascular events;

Countries

China

Contacts

Public ContactHe Liyun

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medicine Sciences

hely3699@163.com+86 13581770875

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026